Advanced Quantitative Imaging Techniques for Personalized Radiotherapy and Lung Toxicity Avoidance
This activity provides an in-depth exploration of advanced quantitative imaging techniques for personalized radiotherapy, focusing on addressing barriers to clinical implementation and improving the management of lung toxicity.
Category
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $229.00
The Role for Consolidative Local Therapy in Stage IV Non-Small Cell Lung Cancer for Oligometastases and Beyond: How are We Improving Outcomes for Patients?
Patients with Stage IV Lung cancer vary in their response to the numerous systemic therapies and are living longer. The role of aggressive local therapy or metastatic directed therapy (MDT) is critical for radiation oncologists and surgeons.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Advancing Our Multi-Disciplinary Understanding of the Cardiovascular Considerations with Radiation Therapy
While radiation therapy (RT) is a highly effective treatment for many solid tumors, thoracic RT carries a risk of cardiovascular (CV) morbidity and mortality that limits critical gains in cancer control and survival.
Category
  • Nonmalignant RT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
ASTRO/ESTRO Joint Session – Overview of ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guidelines: Case-Based Interactive Discussion
One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer
There is a high degree of variability in the management and even the understanding of the oligometastatic state in lung malignancies, or indeed in the context of any solid tumor.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Difficult Cases in Lung SBRT
This activity focuses on difficult cases in the use of lung SBRT. It includes a set of challenging cases followed by a short didactic session on each challenging topic. The cases/topics include: 1) SBRT for a large (>5 cm) primary, node negative tumor.
Category
  • SBRT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Prevention and Management of Toxicity in Organs at Risk (OAR) in a Community Setting
This activity focuses entirely on issues related to the Organs at Risk (OAR) in the setting of thoracic radiation. Discussion centers on protecting the OARs and managing acute and late toxicities. Each speaker focuses on a different clinical situation.
Category
  • SBRT
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
There are many ongoing advances in the multidisciplinary management of stage III NSCLC, in particular the advent of neoadjuvant immunotherapy in patients who are resectable.
Category
  • Immunotherapy
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00